The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial

被引:8
|
作者
Heimburger, Sebastian M. N. [1 ,2 ,3 ]
Hoe, Bjorn [1 ,4 ]
Nielsen, Chris N. [1 ]
Bergmann, Natasha C. [1 ]
Hartmann, Bolette [3 ,5 ]
Holst, Jens J. [3 ,5 ]
Vilsboll, Tina [1 ,2 ,4 ]
Dejgaard, Thomas F. [1 ,2 ]
Christensen, Mikkel B. [1 ,4 ,6 ,7 ]
Knop, Filip K. [1 ,2 ,3 ,4 ]
机构
[1] Univ Copenhagen, Gentofte Hosp, Ctr Clin Metab Res, Hellerup, Denmark
[2] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
[6] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark
[7] Univ Copenhagen, Bispebjerg Hosp, Copenhagen Ctr Translat Res, Copenhagen, Denmark
关键词
Adipose tissue; Continuous glucose monitoring; GIP; Glucose-dependent insulinotropic polypeptide; Glycaemic control; Glycaemic time in range; Hypoglycaemia; Hypoglycaemic events; Insulin resistance; Insulin sensitivity; RECEPTOR AGONIST; GLUCAGON; HYPOGLYCEMIA; RESPONSES;
D O I
10.1007/s00125-021-05547-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Type 1 diabetes is characterised by reduced glucagon response to hypoglycaemia, increasing the risk of insulin treatment-associated hypoglycaemia known to hamper glycaemic control. We previously reported a glucagonotropic effect of exogenous glucose-dependent insulinotropic polypeptide (GIP) during insulin-induced hypoglycaemia in individuals with type 1 diabetes. Here we investigate the effect of a 6-day s.c. GIP infusion on time in glycaemic range as assessed by continuous glucose monitoring (CGM) in individuals with type 1 diabetes. Methods In a randomised, placebo-controlled, double-blind crossover study, time in glycaemic range (assessed by double-blinded CGM) was evaluated in 20 men with type 1 diabetes (18-75 years, stable insulin treatment >= 3 months, diabetes duration 2-15 years, fasting plasma C-peptide below 200 pmol/l, BMI 20-27 kg/m(2), HbA(1c) <69 mmol/mol [8.5%]) during two x 6 days of continuous s.c. GIP (6 pmol kg(-1) min(-1)) and placebo (saline [154 mmol/l NaCl]) infusion, respectively, with an interposed 7-day washout period. The primary outcome was glycaemic time below range, time in range and time above range. Results There were no significant differences in time below range (<3.9 mmol/l, p = 0.53) or above range (>10 mmol/l, p = 0.32) during night-time or daytime, in mean glucose, or in hypoglycaemic events as assessed by CGM. GIP altered neither self-reported hypoglycaemia nor safety measures. Compared with placebo, GIP significantly increased time in tight range (3.9-7.8 mmol/l) during daytime (06:00-23:59 hours) by [mean +/- SEM] 11.2 +/- 5.1% [95% CI 0.41, 21.9] (p = 0.02). Conclusions/interpretation Six-day s.c. GIP infusion in men with type 1 diabetes did not procure convincing effect on overall time in range, but increased time in tight glycaemic range during daytime by similar to 2 h per day.
引用
收藏
页码:2425 / 2431
页数:7
相关论文
共 50 条
  • [21] Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial
    Barnett, Anthony H.
    Huisman, Holger
    Jones, Russell
    von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans-Juergen
    LANCET, 2013, 382 (9902) : 1413 - 1423
  • [22] Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial
    Korsatko, Stefan
    Jensen, Lene
    Brunner, Martina
    Sach-Friedl, Stefanie
    Tarp, Maja D.
    Holst, Anders G.
    Heller, Simon R.
    Pieber, Thomas R.
    DIABETES OBESITY & METABOLISM, 2018, 20 (11) : 2565 - 2573
  • [23] The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial
    Amani M. Ali
    Maggie M. Abbassi
    Nirmeen A. Sabry
    May Fawzi
    Shrook Mousa
    European Journal of Nutrition, 2023, 62 : 3241 - 3249
  • [24] The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial
    Najafipour, Mostafa
    Najafipour, Farzad
    Ostadrahimi, Alireza
    Ghavami, Maryam
    Razaghi, Zohreh
    Tutunchi, Helda
    Alamdari, Naimeh Mesri
    HEALTH PROMOTION PERSPECTIVES, 2024, 14 (04): : 380 - 387
  • [25] The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial
    Ali, Amani M. M.
    Abbassi, Maggie M. M.
    Sabry, Nirmeen A. A.
    Fawzi, May
    Mousa, Shrook
    EUROPEAN JOURNAL OF NUTRITION, 2023, 62 (08) : 3241 - 3249
  • [26] Efficacy of Pomegranate Seed Powder on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes: A Prospective Randomized Double-Blind Placebo-Controlled Clinical Trial
    Hashemi, Monire Seyed
    Namiranian, Nasim
    Tavahen, Hemaseh
    Dehghanpour, Abolfazl
    Rad, Mohammad Hadi
    Jam-Ashkezari, Saeedeh
    Emtiazy, Majid
    Hashempur, Mohammad Hashem
    COMPLEMENTARY MEDICINE RESEARCH, 2021, 28 (03) : 226 - 233
  • [27] Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial
    Kellow, Nicole J.
    Coughlan, Melinda T.
    Savige, Gayle S.
    Reid, Christopher M.
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [28] Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial
    Na, Li-Xin
    Li, Ying
    Pan, Hong-Zhi
    Zhou, Xian-Li
    Sun, Dian-Jun
    Meng, Man
    Li, Xiao-Xia
    Sun, Chang-Hao
    MOLECULAR NUTRITION & FOOD RESEARCH, 2013, 57 (09) : 1569 - 1577
  • [29] The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
    Mozaffari-Khosravi, Hassan
    Talaei, Behrouz
    Jalali, Beman-Ali
    Najarzadeh, Azadeh
    Mozayan, Mohammad Reza
    COMPLEMENTARY THERAPIES IN MEDICINE, 2014, 22 (01) : 9 - 16
  • [30] A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia
    Saito, Itori
    Azuma, Kyoichi
    Kakikawa, Taro
    Oshima, Nobuyuki
    Hanson, Mary E.
    Tershakovec, Andrew M.
    LIPIDS IN HEALTH AND DISEASE, 2015, 14